VNLG-152

N/A

Report date: 2024/04/18 13:54:27
NME

Base Information

Drug NameVNLG-152
Drug Alias NameVNLG-152HT-003HT 003DHT 003IBD
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 2 antagonistsRetinoic acid metabolism modulators
TargetsToll like receptor 2
Therapy Area/IndicationsPsoriasisAcne VulgarisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Maryland, BaltimoreIsoprene Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesReprocell IncUniversity Of Maryland, BaltimoreHoth Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsPsoriasisAcne VulgarisNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A